TSHA
Taysha Gene Therapies, Inc. Common Stock
$5.86
-0.26%
-0.01
Notify me if price changes either direction
Buy TSHA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.7B
Enterprise value
1.5B
Trailing PE
2.5317461
Forward PE
-13.471265
PEG Ratio
0.050634922
Enterprise to EBITDA
-11.264
Enterprise to revenue
198.129
Price to book MRQ
7.9403796
Price to sales TTM
225.39629
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
7.5M
EBITDA
-131406000
Diluted EPS TTM
-0.38
Total Cash (MRQ)
276.6M
Current ratio (MRQ)
14.044
Operating Cash Flow (TTM)
-111948000
TSHA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
